Mercy Memorial Hospital Corporation

Mercy Memorial Hospital Corporation was paid $1.18M by Medicaid between Jan 2019 and May 2024, across 107 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 11% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in Michigan

Rank by total paid#40 of 108

Median peer was paid$588K

This provider vs. median2.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2019	8,098	$40K
2020	9,931	$129K
2021	12,210	$172K
2022	37,668	$325K
2023	38,637	$355K
2024incomplete	16,477	$161K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	11%	2,058	2,003	$130K
84443	Thyroid stimulating hormone (TSH)	7.7%	8,726	8,546	$91K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	6.2%	3,973	3,943	$74K
80053	Comprehensive metabolic panel	5.1%	8,986	8,365	$60K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	5.1%	2,624	2,609	$60K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	5.1%	2,624	2,609	$60K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	4.7%	11,378	10,443	$55K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	4.5%	1,361	1,291	$54K
80061	Lipid panel	4.4%	6,268	6,249	$52K
84439		2.9%	6,110	5,965	$34K
82607		2.4%	2,890	2,876	$28K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	2.3%	1,522	1,522	$27K

95 more codes

81514		2.2%	143	$26K
83036	Hemoglobin; glycosylated (A1C)	2.2%	4,123	$25K
88305	Level IV - Surgical pathology, gross and microscopic examination	2.0%	784	$24K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	1.9%	1,460	$22K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	1.7%	549	$20K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	1.6%	950	$19K
87150		1.2%	657	$14K
82746		1.2%	1,398	$14K
87086	Culture, bacterial; quantitative colony count, urine	1.2%	2,717	$14K
80048	Basic metabolic panel (calcium, ionized)	1.1%	2,555	$14K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	1.0%	528	$12K
84702		<1%	1,205	$12K
86696		<1%	890	$11K
83735		<1%	2,403	$11K
86780		<1%	1,191	$10K
82728		<1%	1,094	$10K
84481		<1%	891	$10K
85027		<1%	2,323	$9K
86803		<1%	989	$9K
86850		<1%	1,341	$9K
83550		<1%	1,482	$9K
84403		<1%	419	$7K
83540		<1%	1,679	$7K
82670		<1%	374	$7K
83001		<1%	534	$7K
80074		<1%	199	$6K
83970		<1%	211	$6K
87340		<1%	851	$6K
80076		<1%	1,047	$6K
85610		<1%	1,942	$5K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	33	$5K
86762		<1%	455	$4K
81001		<1%	2,247	$4K
87077		<1%	740	$4K
86038		<1%	512	$4K
82784		<1%	354	$4K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	57	$4K
82570		<1%	1,029	$4K
84146		<1%	280	$4K
83525		<1%	459	$4K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	127	$3K
86901		<1%	1,343	$3K
86900		<1%	1,343	$3K
87081		<1%	645	$3K
82043		<1%	663	$3K
86140		<1%	719	$2K
86364		<1%	173	$2K
82105		<1%	180	$2K
85730		<1%	488	$2K
87186		<1%	337	$2K
87480		<1%	143	$2K
87660		<1%	143	$2K
87510		<1%	141	$2K
86695		<1%	205	$2K
86003		<1%	25	$2K
83002		<1%	133	$2K
84144		<1%	115	$2K
84460		<1%	397	$1K
85652		<1%	746	$1K
82550		<1%	281	$1K
87522	Neg quan hep c or qual rna	<1%	44	$1K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	16	$1K
81003		<1%	757	$1K
82565		<1%	313	$1K
83655		<1%	121	$1K
84450		<1%	288	$991.84
86376		<1%	101	$986.55
82950		<1%	303	$956.59
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	50	$839.32
86706		<1%	77	$553.50
84156		<1%	228	$549.81
84153		<1%	43	$534.89
87581		<1%	33	$508.44
87486		<1%	32	$485.33
36415	Collection of venous blood by venipuncture	<1%	9,884	$448.86
82248		<1%	130	$418.24
86704		<1%	51	$404.57
86787		<1%	39	$361.52
83615		<1%	90	$346.36
84550		<1%	100	$295.02
82533		<1%	26	$284.92
87070		<1%	53	$254.66
82785		<1%	24	$254.58
83516		<1%	13	$233.46
83690		<1%	43	$201.24
82627		<1%	13	$190.32
84425		<1%	13	$182.27
86431		<1%	42	$158.44
82310		<1%	40	$137.61
86800		<1%	12	$127.53
86708		<1%	12	$102.60
87807		<1%	12	$101.26
87205		<1%	27	$68.51
84100		<1%	17	$53.70
85651		<1%	12	$40.81

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSCHWANKE, DAN (INTERIM PRESIDENT)